Australia: Supporting evidence in patent specifications

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Australia: Supporting evidence in patent specifications

The recent Full Federal Court case of Morellini v Mizzi Family Holdings Pty Ltd [2016] FCAFC 13 has highlighted the danger of using unsupported assertions in patent specifications.

The technology of the case dealt with sugar cane planting, with the applicant committing a fatal error in asserting: "it is found that" inclining a soil mound by about 40 degrees provided superior warming of the soil by the sun.

During prosecution, the applicant had argued the soil mound inclination was a significant feature of the claim that distinguished it from the prior art.

The problem was that there was no evidence that the soil mound incline had any effect on heating of the soil. The applicant tried to argue that this was part of their "own experience and conclusions". However the Court rejected this argument as totally speculative.

The Court concluded the patent was invalid for false suggestion or misrepresentation. Hence, the applicant's somewhat innocuous use of the term "it has been found", rather than say "it is conjectured, thought or believed", has led to the destruction of its patent rights.

The obvious takeaway from the case is to review specifications to revise assertions that are not backed by evidence.

treloar.jpg

Peter Treloar


Shelston IPLevel 21, 60 Margaret StreetSydney NSW 2000, AustraliaTel: +61 2 9777 1111Fax: +61 2 9241 4666email@shelstonip.comwww.shelstonip.com

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article